ARCHIVES

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

This article is from The Cancer Letter archive.

Vol. 17 No. 30 | July 26, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources

October 24, 1980

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010